Cargando…

Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1

Detalles Bibliográficos
Autores principales:	Antoniou, Miranta, Kolamunnage-Dona, Ruwanthi, Jorgensen, Andrea L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023546/ https://www.ncbi.nlm.nih.gov/pubmed/29735910 http://dx.doi.org/10.3390/jpm8020017

Ejemplares similares

Correction: Antoniou, M.; et al. Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size. J. Pers. Med. 2017, 7, 19
por: Antoniou, Miranta, et al.
Publicado: (2018)

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
por: Antoniou, Miranta, et al.
Publicado: (2016)

Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
por: Antoniou, Miranta, et al.
Publicado: (2017)

Evaluating statistical characteristics of biomarker-guided trial designs
por: Antoniou, Miranta, et al.
Publicado: (2015)

Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size
por: Antoniou, Miranta, et al.
Publicado: (2017)

A final word from outgoing Student editor, Sophia Antoniou
por: Antoniou, Sophia
Publicado: (2021)

Bayesian joint modelling of longitudinal and time to event data: a methodological review
por: Alsefri, Maha, et al.
Publicado: (2020)

Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues
por: Hickey, Graeme L., et al.
Publicado: (2016)

joineRML: a joint model and software package for time-to-event and multivariate longitudinal outcomes
por: Hickey, Graeme L., et al.
Publicado: (2018)

Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review
por: Stevens, David, et al.
Publicado: (2021)

Correction: Brauner et al. Dental Management of Maxillofacial Ballistic Trauma. J. Pers. Med. 2022, 12, 934
por: Brauner, Edoardo, et al.
Publicado: (2023)

Sample size formula for joint modelling of longitudinal and time-to-event data in clinical trials
por: Powney, Matthew, et al.
Publicado: (2013)

Adjusting for informative missing outcome data in clinical trials with longitudinal study designs
por: Kolamunnage-Dona, Ruwanthi, et al.
Publicado: (2013)

Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study
por: Kolamunnage-Dona, Ruwanthi, et al.
Publicado: (2016)

Joint models for longitudinal and time-to-event data: a review of reporting quality with a view to meta-analysis
por: Sudell, Maria, et al.
Publicado: (2016)

Correction to: joint models for longitudinal and time-to-event data: a review of reporting quality with a view to meta-analysis
por: Sudell, Maria, et al.
Publicado: (2018)

Time-dependent ROC curve analysis in medical research: current methods and applications
por: Kamarudin, Adina Najwa, et al.
Publicado: (2017)

A review of the handling of missing longitudinal outcome data in clinical trials
por: Powney, Matthew, et al.
Publicado: (2014)

Investigation of 2‐stage meta‐analysis methods for joint longitudinal and time‐to‐event data through simulation and real data application
por: Sudell, Maria, et al.
Publicado: (2017)

Investigation of one‐stage meta‐analysis methods for joint longitudinal and time‐to‐event data through simulation and real data application
por: Sudell, Maria, et al.
Publicado: (2018)

Letter to the editor: Response to Giardiello D, Antoniou AC, Mariani L, Easton DF, Steyerberg EW
por: Ming, Chang, et al.
Publicado: (2020)

Cardiovascular drugs and COVID‐19 clinical outcomes: A living systematic review and meta‐analysis
por: Asiimwe, Innocent G., et al.
Publicado: (2021)

Correction: Rivera-Picón et al. Factors Associated with Adherence to Treatment in Patients with HIV and Diabetes Mellitus. J. Pers. Med. 2023, 13, 269
por: Rivera-Picón, Cristina, et al.
Publicado: (2023)

Spatial and spatio-temporal statistical analyses of retinal images: a review of methods and applications
por: Zhu, Wenyue, et al.
Publicado: (2020)

Cardiovascular drugs and COVID‐19 clinical outcomes: a systematic review and meta‐analysis of randomized controlled trials
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Assessment and clinical course of hypocalcemia in critical illness
por: Steele, Tom, et al.
Publicado: (2013)

Correction to Yang T, et al. Chin Med J 2022;135:672-680.
Publicado: (2022)

Adjusting for treatment changes in epilepsy: causal analysis of randomised controlled trial survival outcomes in the presence of departure from randomised treatment
por: Dodd, Susanna, et al.
Publicado: (2013)

Reply to Veerman et al. Comment on “Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410”
por: Rosenzweig, Barak, et al.
Publicado: (2022)

Assessing the potential for outcome reporting bias in a review: a tutorial
por: Dwan, Kerry, et al.
Publicado: (2010)

Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410
por: Veerman, Hans, et al.
Publicado: (2022)

Correction: Saratale et al. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. J. Pers. Med. 2022, 12, 349
por: Saratale, Ganesh Dattatraya, et al.
Publicado: (2022)

TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy
por: Pushpakom, Sudeep, et al.
Publicado: (2020)

Myxoma of the Ovary: in Regard to Bedir et al. (Balkan Med J 2018;35:120-121)
por: Sterkers, Nicolas, et al.
Publicado: (2019)

Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response
por: Kovanda, Laura L., et al.
Publicado: (2017)

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review
por: Stevens, David, et al.
Publicado: (2021)

Spatial Linear Mixed Effects Modelling for OCT Images: SLME Model †
por: Zhu, Wenyue, et al.
Publicado: (2020)

Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655
por: Kao, Chieh-Ni, et al.
Publicado: (2022)

Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy
por: Pushpakom, Sudeep P, et al.
Publicado: (2015)

Erratum to “The Level of Serum and Urinary Nephrin in Normal Pregnancy and Pregnancy with Subsequent Preeclampsia” by Jung YJ, et al. (Yonsei Med J 2017;58(2):401–406.)
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pk561ms1m7qicqbelclhp0aun0